1-6 of 6
Yutaka Imamura, MD
Close
Sort by
Journal Articles

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)

Hirohiko Shibayama, MD PhD, Tatsuya Kawaguchi, MD PhD, Junya Kuroda, MD PhD, Hirohisa Nakamae, MD PhD, Itaru Matsumura, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tomohiko Kamimura, MD PhD, Kentaro Fukushima, MD PhD, Yutaka Imamura, MD PhD, Tetsuya Eto, MD PhD, Kazutaka Sunami, MD PhD, Mototsugu Shimokawa, PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1914.
https://doi.org/10.1182/blood.V128.22.1914.1914
Published: 2016
Journal Articles

Discontinuation of Nilotinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Deep Molecular Responses for at Least 2 Years: A Multicenter Phase 2 Stop Nilotinib (Nilst) Trial

Norimitsu Kadowaki, MD PhD, Tatsuya Kawaguchi, MD PhD, Junya Kuroda, MD PhD, Hirohisa Nakamae, MD PhD, Itaru Matsumura, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Koji Nagafuji, MD PhD, Yutaka Imamura, MD PhD, Hirohito Yamazaki, Mototsugu Shimokawa, PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2016) 128 (22): 790.
https://doi.org/10.1182/blood.V128.22.790.790
Published: 2016
Journal Articles

Prognostic Significance Of S-Phase Kinase-Associated Protein 2 (Skp2) In DLBCL Patients Treated With Upfront Autologous Peripheral Blood Stem Cell Transplantation

Takashi Okamura, MD, PhD, Ritsuko Seki, PhD, Koji Nagafuji, MD, PhD, Kisato Nosaka, MD, PhD, Takeshi Tsuchiya, MD, PhD, Hiroyuki Tsuda, M.D, PhD, Toshihiro Miyamoto, MD, Masakazu Higuchi, MD, PhD, Hitoshi Suzushima, MD, PhD, Michihiro Hidaka, MD, PhD, Abe Yasunobu, MD, PhD, Yuji Yufu, MD, PhD, Yutaka Imamura, MD, PhD, Masahiro Iwahashi, MD, PhD, Tomoaki Fujisaki, MD, PhD, Naokuni Uike, MD, PhD, Moriuchi Yukiyoshi, MD, PhD, Tetsuya Eto, MD, PhD, Gondo Hisashi, MD, PhD, Tomohiko Kamimura, MD PhD, Yasushi Takamatsu, MD, PhD, Ohshima Koichi, MD PhD
Journal: Blood
Blood (2013) 122 (21): 3022.
https://doi.org/10.1182/blood.V122.21.3022.3022
Published: 2013
Journal Articles

Once-Weekly Subcutaneous Bortezomib Plus Oral Cyclophosphamide and Dexamethasone Therapy For Relapsed Or Refractory Multiple Myeloma

Yasushi Takamatsu, MD, PhD, Yutaka Imamura, MD, Tomonori Nakazato, MD, Naokuni Uike, MD, PhD, Kaname Miyashita, MD, Yoshio Saburi, MD, PhD, Naoki Harada, MD, Shuichi Ota, MD, PhD, Rie Imamura, MD, Toshihiro Miyamoto, MD
Journal: Blood
Blood (2013) 122 (21): 5382.
https://doi.org/10.1182/blood.V122.21.5382.5382
Published: 2013
Journal Articles

Natural History of 33 Patients with Upshaw-Schulman Syndrome Has Revealed That All the Gravida Develop Thrombocytopenia, Often Followed by Thrombotic Microangiopathy with Stillbirth.

Yoshihiro Fujimura, MD, Masanori Matsumoto, MD, Koichi Kokame, PhD, Hideo Yagi, MD, Ayami Isonishi, PhD, Tomomi Matsuyama, MD, Seiji Kato, PhD, Hiromichi Ishizashi, PhD, Yasuaki Shida, MD, Nishio Kenji, MD, Nobu Akiyama, MD, Junji Tomiyama, MD, Kazuhiro Natori, MD, Yasunobu Kuraishi, MD, Yutaka Imamura, MD, Nobumasa Inoue, MD, Satoshi Higasa, MD, Masako Seike, MD, Teruhiko Kozuka, MD, Masamichi Hara, MD, Mitsuhiko Sugimoto, MD, Hideo Wada, MD, Mitsuru Murata, MD, Toshiyuki Miyata, PhD, Yasuo Ikeda, MD
Journal: Blood
Blood (2007) 110 (11): 3211.
https://doi.org/10.1182/blood.V110.11.3211.3211
Published: 2007
Journal Articles

Target Dose Adjustment of Oral Busulfan Using a Test Dose in Japanese Adults Undergoing Hematopoietic Stem Cell Transplantation.

Yasushi Takamatsu, MD, Kentaro Ogata, PhD, Noriaki Sasaki, PhD, Shuuji Hara, PhD, Tetsuya Eto, MD, Kouji Kato, MD, Kouji Nagafuji, MD, Yasunobu Abe, MD, Akira Kubota, MD, Ilseung Choi, MD, Rie Imamura, MD, Yutaka Imamura, MD, Naoya Taira, MD, Junji Suzumiya, MD, Kazuo Tamura, MD
Journal: Blood
Blood (2005) 106 (11): 5313.
https://doi.org/10.1182/blood.V106.11.5313.5313
Published: 2005